title: Arginine deiminase inhibits Porphyromonas gingivalis surface attachment.
abstract: The oral cavity is host to a complex microbial community whose maintenance depends on an array of cell-to-cell interactions and communication networks, with little known regarding the nature of the signals or mechanisms by which they are sensed and transmitted. Determining the signals that control attachment, biofilm development and outgrowth of oral pathogens is fundamental to understanding pathogenic biofilm development. We have previously identified a secreted arginine deiminase (ADI) produced by Streptococcus intermedius that inhibited biofilm development of the commensal pathogen Porphyromonas gingivalis through downregulation of genes encoding the major (fimA) and minor (mfa1) fimbriae, both of which are required for proper biofilm development. Here we report that this inhibitory effect is dependent on enzymic activity. We have successfully cloned, expressed and defined the conditions to ensure that ADI from S. intermedius is enzymically active. Along with the cloning of the wild-type allele, we have created a catalytic mutant (ADIC399S), in which the resulting protein is not able to catalyse the hydrolysis of l-arginine to l-citrulline. P. gingivalis is insensitive to the ADIC399S catalytic mutant, demonstrating that enzymic activity is required for the effects of ADI on biofilm formation. Biofilm formation is absent under l-arginine-deplete conditions, and can be recovered by the addition of the amino acid. Taken together, the results indicate that arginine is an important signal that directs biofilm formation by this anaerobe. Based on our findings, we postulate that ADI functions to reduce arginine levels and, by a yet to be identified mechanism, signals P. gingivalis to alter biofilm development. ADI release from the streptococcal cell and its cross-genera effects are important findings in understanding the nature of inter-bacterial signalling and biofilm-mediated diseases of the oral cavity.
authors.affiliation: Department of Oral Medicine Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.|Department of Molecular Genetics, The Forsyth Institute, Cambridge, MA, USA.
authors.forename: Carla
authors.initials: C
authors.lastname: Cugini
authors.affiliation: Department of Periodontology, The Forsyth Institute, Cambridge, MA, USA.
authors.forename: Danielle N
authors.initials: DN
authors.lastname: Stephens
authors.affiliation: Department of Periodontology, The Forsyth Institute, Cambridge, MA, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Nguyen
authors.affiliation: Department of Periodontology, The Forsyth Institute, Cambridge, MA, USA.
authors.forename: Alpdogan
authors.initials: A
authors.lastname: Kantarci
authors.affiliation: Department of Oral Medicine Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.|Department of Molecular Genetics, The Forsyth Institute, Cambridge, MA, USA.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Davey
mesh_terms: D001120:Arginine / Q000378:metabolism*; D001422:Bacterial Adhesion / Q000187:drug effects*; D018441:Biofilms / Q000254:growth & development*; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D006867:Hydrolases / Q000378:metabolism*; D056265:Microbial Interactions; D008969:Molecular Sequence Data; D016966:Porphyromonas gingivalis / Q000187:drug effects / Q000502:physiology*; D017422:Sequence Analysis, DNA; D034367:Streptococcus intermedius / Q000201:enzymology*
chemical_list: D004269:DNA, Bacterial; D001120:Arginine; D006867:Hydrolases; C019723:arginine deiminase